The defence conglomerate CSG is heading into Poland’s MSPO arms fair in Kielce this week with a crowded exhibition stand — and an uncomfortable gap between its operational momentum and what its share price is saying.
From September 8-11, the group will showcase products from no fewer than eight subsidiaries, spanning Tatra Export, Excalibur Army, Tatra Defence, MSM Group, Vývoj Martin, AviaNera Technologies, CSG Polska and Domar MS. The display is designed to telegraph the breadth of a portfolio that now stretches from land systems and ammunition to propulsion technology.
Yet investors have spent recent weeks voting with their feet. The stock closed Friday at €16.61, down 2.5 percent on the day, and has shed 11 percent over the past seven trading sessions. That extends a slide that has now carved 54 percent off the share price since its 52-week high of €36.05 at the end of January.
Orders Are Piling Up — But So Is the Investment Bill
The timing of the trade-show appearance is telling. Just days before the MSPO announcement, CSG disclosed fresh orders for bridge-laying vehicles worth more than $50 million from customers across Europe, the Middle East and Southeast Asia. The group’s order backlog, including pipeline, had already climbed to €46 billion by the half-year mark, up from €44 billion in March.
That demand is translating into hard numbers. First-half revenue rose 17.2 percent to €3,251 million, with the Defence Systems division leading the charge at 27.0 percent growth. Operating EBIT advanced 12.7 percent to €784 million, keeping the margin at 24.1 percent — within the guided range.
Management has also reaffirmed its full-year outlook of €7.4-7.6 billion in revenue at an operating EBIT margin of 24-25 percent, along with medium-term targets for organic growth in the mid-teens percentage range and margin expansion to 26-28 percent.
The catch: CSG is ploughing roughly €50 million into expanding production capacity for military systems, a step Reuters has linked to the group’s broader defence build-out. That follows several agreements in recent months to extend manufacturing operations in Poland. For shareholders, the reinvestment is a double-edged sword — it positions the group for future growth but can weigh on margins in the near term, even with defence demand running hot.
A Changing Revenue Mix
One of the more striking developments buried in the half-year numbers is the shifting geography of CSG’s business. Revenue from Ukraine has fallen to 17 percent of the total, down from 27 percent at the end of 2025. Europe excluding Ukraine now accounts for more than half of group sales — a rebalancing that CSG itself frames as an improvement in earnings quality, given the greater stability of those markets.
Should investors sell immediately? Or is it worth buying CSG?
The Land Systems division has become the largest contributor to the order book and has doubled its revenue within a year. The group has also completed its acquisition of Domar MS, a maker of wiring harnesses and specialist connectors for defence systems, which was first announced in the first quarter.
Financing Costs Trimmed, New Ventures Launched
Alongside the operational push, CSG has refinanced its credit facilities, shaving 125-150 basis points off financing costs and extending maturities to six years.
New ventures are also taking shape. Firecrest Aerospace, a joint venture between CSE USA and CSG subsidiary AviaNera Technologies, is gearing up to mass-produce turbojet and turbofan engines for unmanned systems in Wisconsin. Full production is targeted for 2027, with output planned to scale from hundreds to thousands of units annually.
AviaNera has separately struck a strategic partnership with Ukrainian Armor to supply propulsion systems for Ukrainian guided missiles and unmanned platforms, with the potential for production to be localised in Ukraine down the line.
Where the Market Sits Now
Technical indicators suggest the sell-off may be running out of steam. The relative strength index stands at 40.1, hovering in neutral-to-slightly-oversold territory, while the share price sits almost exactly on its 50-day moving average of €16.59. Still, the annualised volatility of 52 percent underscores just how jittery trading in the stock has become.
No single catalyst explains the recent weakness — the operational news flow has been consistently positive. The market appears to be waiting for evidence that CSG can deliver on its promise to unwind elevated working capital in the second half. Whether the MSPO showcase convinces investors will likely depend on that, and on whether the capacity investments translate into further large contract wins.
The next set of financial results is scheduled for November 11.
Ad
CSG Stock: Buy or Sell?! New CSG Analysis from September 6 delivers the answer:
The latest CSG figures speak for themselves: Urgent action needed for CSG investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 6.
CSG: Buy or sell? Read more here...
